Moleculin Biotech Inc (NASDAQ:MBRX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MBRX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MBRX

  • Market Cap$106.100m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS60855D2009

Company Profile

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with its focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.

Latest MBRX news

Currently there for this company. Visit our news hub for other news .